Metabolic and Neurologic Diseases and Marine Natural Products
A special issue of Marine Drugs (ISSN 1660-3397). This special issue belongs to the section "Marine Pharmacology".
Deadline for manuscript submissions: 30 April 2024 | Viewed by 255
Special Issue Editors
Interests: metabolic diseases; glucose metabolism; lipid metabolism; insulin signaling; Alzheimer's disease; neurodegenerative diseases; anti-inflammatory agents; nutraceuticals; bioactive natural products
Interests: metabolic diseases; glucose metabolism; lipid metabolism; insulin signaling; Alzheimer's disease; neurodegenerative diseases; anti-inflammatory agents; nutraceuticals; bioactive natural products
Special Issue Information
Dear Colleagues,
Metabolic disorders leading to metabolic pathologies, such as obesity, dyslipidemia, hyperglycemia or glucose intolerance, hyperinsulinemia or insulin resistance and arterial hypertension in a genetically susceptible population, and hormonal and environmental factors, have a marked negative impact on the central nervous system and cognition. This is a proinflammatory state that probably contributes to neuroinflammation and neurodegeneration. The marine environment offers a rich source of structurally novel, natural products with significant diverse bioactivities that have been successfully developed as neuroprotective and antihypertrygliceridemia products. Furthermore, the use of bioactive products from marine sources sheds light on the relationship between bioactive marine compounds and cognitive function to treat and prevent metabolic and neurologic disorders.
This Special Issue aims at introducing the bioactive properties of marine natural products for the generation of new compounds or the usefulness of their known components to control metabolic disorders and neurodegeneration.
Dr. Carmen María Claro-Cala
Dr. Maria C. Millan-Linares
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Marine Drugs is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- marine algae
- bioactive marine compounds
- anti-inflammatory activity
- antioxidant activity
- metabolic diseases
- lipid metabolism
- metabolic syndrome
- neuroinflammation
- neurodegeneration
- immunonutrition
- immunometabolism
